DAMPs, ageing, and cancer: The 'DAMP Hypothesis'

Ageing Research Reviews

Volumn 24, Issue , 2015, Pages 3-16

  Huang, Jin ^a   Xie, Yangchun ^a,c   Sun, Xiaofang ^b   Zeh, Herbert J ^c   Kang, Rui ^c   Lotze, Michael T ^c,d   Tang, Daolin ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Ageing; Biomarker; Cancer; Damage associated molecular pattern (DAMP) molecules; Longevity; Receptor

Indexed keywords

CELL PROTEIN; DAMAGE ASSOCIATED MOLECULAR PATTERN MOLECULE; DNA; DOUBLE STRANDED DNA; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE; NUCLEOTIDE; PROTEIN S 100; RNA; SINGLE STRANDED DNA; UNCLASSIFIED DRUG; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; AGING; CELL AGING; CHROMATIN; CHROMOSOME NUMBER; DNA END JOINING REPAIR; DNA METHYLATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EPIGENETICS; EXCISION REPAIR; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNE MEDIATED INJURY; INFLAMMATION; INNATE IMMUNITY; METABOLIC REGULATION; NEOPLASM; PROTEIN FUNCTION; REVIEW; SINGLE STRANDED DNA BREAK; TELOMERE SHORTENING; ANIMAL; METABOLISM; PATHOLOGY;

AGING; ANIMALS; HUMANS; NEOPLASMS; RECEPTORS, PATTERN RECOGNITION;

EID: 84946845377     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.10.004     Document Type: Review

References (294)

1. Ackermann M., et al. On the evolutionary origin of aging. Aging Cell 2007, 6(2):235-244.
2. Agrelo R., et al. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(23):8822-8827.
3. Aguilera A., Gomez-Gonzalez B. Genome instability: a mechanistic view of its causes and consequences. Nat. Rev. Genet. 2008, 9(3):204-217.
4. Allam R., et al. Histones trigger sterile inflammation by activating the NLRP3 inflammasome. Eur. J. Immunol. 2013, 43(12):3336-3342.
5. Allam R., et al. Extracellular histones in tissue injury and inflammation. J. Mol. Med. 2014, 92(5):465-472.
6. Anckar J., Sistonen L. Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu. Rev. Biochem. 2011, 80:1089-1115.
7. Anderson R.M., Weindruch R. Metabolic reprogramming in dietary restriction. Interdisciplin. Top. Gerontol. 2007, 35:18-38.
8. Arrigo A.P. Editorial: heat shock proteins in cancer. Curr. Mol. Med. 2012, 12(9):1099-1101.
9. Artandi S.E., et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406(6796):641-645.
10. Asea A., et al. HSP70 stimulates cytokine production through a CD14-dependant pathway: demonstrating its dual role as a chaperone and cytokine. Nat. Med. 2000, 6(4):435-442.
11. Balch W.E., et al. Adapting proteostasis for disease intervention. Science 2008, 319(5865):916-919.
12. Bald T., et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 2014, 507(7490):109-113.
13. Balistreri C.R., et al. NF-kappaB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies. Immun. Ageing 2013, 10(1):24.
14. Bao L., et al. The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence. FEBS J. 2012, 279(24):4576-4588.
15. Basen-Engquist K., Chang M. Obesity and cancer risk: recent review and evidence. Curr. Oncol. Rep. 2011, 13(1):71-76.
16. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000, 9(16):2395-2402.
17. Bianchi G., et al. p53 and p66 proteins compete for hypoxia-inducible factor 1 alpha stabilization in young and old rat hearts exposed to intermittent hypoxia. Gerontology 2006, 52(1):17-23.
18. Bianchi R., et al. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J. Biol. Chem. 2011, 286(9):7214-7226.
19. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81(1):1-5.
20. Binder R.J. Hsp receptors: the cases of identity and mistaken identity. Curr. Opin. Mol. Ther. 2009, 11(1):62-71.
21. Blanco R., et al. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev. 2007, 21(2):206-220.
22. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6(8):611-622.
23. Blasco M.A. The epigenetic regulation of mammalian telomeres. Nat. Rev. Genet. 2007, 8(4):299-309.
24. Bollati V., et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech. Ageing Dev. 2009, 130(4):234-239.
25. Bonaldi T., et al. The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J. 2002, 21(24):6865-6873.
26. Boukamp P., Popp S., Krunic D. Telomere-dependent chromosomal instability. J. Invest. Dermatol. Symp. Proc. 2005, 10(2):89-94.
27. Broers J.L., et al. Nuclear lamins: laminopathies and their role in premature ageing. Physiol. Rev. 2006, 86(3):967-1008.
28. Burhans W.C., Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 2007, 35(22):7545-7556.
29. Burke S.N., Barnes C.A. Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 2006, 7(1):30-40.
30. Burke B., Stewart C.L. The nuclear lamins: flexibility in function. Nat. Rev. Mol. Cell Biol. 2013, 14(1):13-24.
31. Calderwood S.K., et al. Extracellular heat shock proteins in cell signaling. FEBS Lett. 2007, 581(19):3689-3694.
32. Calogero S., et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 1999, 22(3):276-280.
33. Campisi J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 2013, 75:685-705.
34. Campos E.I., Reinberg D. Histones: annotating chromatin. Annu. Rev. Genet. 2009, 43:559-599.
35. Canto C., Auwerx J. Caloric restriction, SIRT1 and longevity. Trends Endocrinol. Metab. 2009, 20(7):325-331.
36. Carranco R., et al. Repression by an auxin/indole acetic acid protein connects auxin signaling with heat shock factor-mediated seed longevity. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(50):21908-21913.
37. Carta S., et al. DAMPs and inflammatory processes: the role of redox in the different outcomes. J. Leukoc. Biol. 2009, 86(3):549-555.
38. Celeste A., et al. Genomic instability in mice lacking histone H2AX. Science 2002, 296(5569):922-927.
39. Celona B., et al. Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol. 2011, 9(6):e1001086.
40. Chang S. Modeling aging and cancer in the telomerase knockout mouse. Mutat. Res. 2005, 576(1-2):39-53.
41. Chen R., et al. Release and activity of histone in diseases. Cell Death Dis. 2014, 5:pe1370.
42. Chen H., et al. S100 protein family in human cancer. Am. J. Cancer Res. 2014, 4(2):89-115.
43. Chiang H.L., et al. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 1989, 246(4928):382-385.
44. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368(7):651-662.
45. Christensen B.C., et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009, 5(8):e1000602.
46. Colman R.J., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325(5937):201-204.
47. Cremona C.A., Behrens A. ATM signalling and cancer. Oncogene 2014, 33(26):3351-3360.
48. Cummings C.J., et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 2001, 10(14):1511-1518.
49. Dai C., et al. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007, 130(6):1005-1018.
50. Dang E.V., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146(5):772-784.
51. Dang C.V. Links between metabolism and cancer. Genes Dev. 2012, 26(9):877-890.
52. Davalos A.R., et al. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J. Cell Biol. 2013, 201(4):613-629.
53. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19(18):2100-2110.
54. DeBerardinis R.J., Thompson C.B. Cellular metabolism and disease: what do metabolic outliers teach us?. Cell 2012, 148(6):1132-1144.
55. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis: inflammation, and tumorigenesis. Cancer Cell 2006, 10(1):51-64.
56. Deng C.X. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006, 34(5):1416-1426.
57. Dimauro T., David G. Chromatin modifications: the driving force of senescence and aging?. Aging (Albany NY) 2009, 1(2):182-190.
58. Ding Q., et al. Caloric restriction increases adiponectin expression by adipose tissue and prevents the inhibitory effect of insulin on circulating adiponectin in rats. J. Nutr. Biochem. 2012, 23(8):867-874.
59. Donate L.E., Blasco M.A. Telomeres in cancer and ageing. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2011, 366(1561):76-84.
60. Donato R., et al. Functions of S100 proteins. Curr. Mol. Med. 2013, 13(1):24-57.
61. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr. Mol. Med. 2007, 7(8):711-724.
62. Dorshkind K., Montecino-Rodriguez E., Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat. Rev. Immunol. 2009, 9(1):57-62.
63. Dror V., Winston F. The Swi/Snf chromatin remodeling complex is required for ribosomal DNA and telomeric silencing in Saccharomyces cerevisiae. Mol. Cell. Biol. 2004, 24(18):8227-8235.
64. Egger G., et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429(6990):457-463.
65. Eisenbacher J.L., et al. S100A4 and Uric Acid Promote Mesenchymal Stromal Cell Induction of IL-10+/IDO+ Lymphocytes. J. Immunol. 2014, 192(12):6102-6110.
66. Ellis L., Atadja P.W., Johnstone R.W. Epigenetics in cancer: targeting chromatin modifications. Mol. Cancer Ther. 2009, 8(6):1409-1420.
67. Engelkamp D., et al. Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(14):6547-6551.
68. Enokido Y., et al. Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain. Biochem. Biophys. Res. Commun. 2008, 376(1):128-133.
69. Erjavec N., et al. Accelerated aging and failure to segregate damaged proteins in Sir2 mutants can be suppressed by overproducing the protein aggregation-remodeling factor Hsp104p. Genes Dev. 2007, 21(19):2410-2421.
70. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 2000, 51:245-270.
71. Ertel A., et al. Is cancer a metabolic rebellion against host aging? In the quest for immortality: tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle 2012, 11(2):253-263.
72. Feder M.E., Hofmann G.E. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu. Rev. Physiol. 1999, 61:243-282.
73. Fernandez-Capetillo O., et al. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 2004, 3(8-9):959-967.
74. Feser J., et al. Elevated histone expression promotes life span extension. Mol. Cell 2010, 39(5):724-735.
75. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408(6809):239-247.
76. Finkel T., Serrano M., Blasco M.A. The common biology of cancer and ageing. Nature 2007, 448(7155):767-774.
77. Flannagan R.S., Jaumouille V., Grinstein S. The cell biology of phagocytosis. Annu. Rev. Pathol. 2012, 7:61-98.
78. Foell D., et al. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 2007, 81(1):28-37.
79. Fraga M.F., Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 2007, 23(8):413-418.
80. Fraga M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(30):10604-10609.
81. Fullgrabe J., et al. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature 2013, 500(7463):468-471.
82. Fulop T., et al. Aging: immunity, and cancer. Discov. Med. 2011, 11(61):537-550.
83. Gabai V.L., et al. Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR. Mol. Cell. Biol. 2012, 32(5):929-940.
84. Gao H.M., et al. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 2011, 31(3):1081-1092.
85. Garg A.D., et al. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol. Immunother. 2012, 61(2):215-221.
86. Gazzolo D., et al. Pediatric concentrations of S100B protein in blood: age- and sex-related changes. Clin. Chem. 2003, 49(6 Pt 1):967-970.
87. Gebhardt C., et al. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 2008, 205(2):275-285.
88. Giavara S., et al. Yeast Nhp6A/B and mammalian Hmgb1 facilitate the maintenance of genome stability. Curr. Biol. 2005, 15(1):68-72.
89. Gilson E., Geli V. How telomeres are replicated. Nat. Rev. Mol. Cell Biol. 2007, 8(10):825-838.
90. Gostner J.M., et al. Redox regulation of the immune response. Redox Rep. 2013, 18(3):88-94.
91. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 1985, 43(2 Pt 1):405-413.
92. Guarente L. Sir2 links chromatin silencing: metabolism, and aging. Genes Dev. 2000, 14(9):1021-1026.
93. Han S., Brunet A. Histone methylation makes its mark on longevity. Trends Cell Biol. 2012, 22(1):42-49.
94. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
95. Harman D. The aging process: major risk factor for disease and death. Proc. Natl. Acad. Sci. U.S.A. 1991, 88(12):5360-5363.
96. Harman D. Free radical theory of aging. Mutat. Res. 1992, 275(3-6):257-266.
97. Harpio R., Einarsson R. S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin. Biochem. 2004, 37(7):512-518.
98. Harrison D.E., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460(7253):392-395.
99. Hasegawa A., et al. Alternate day calorie restriction improves systemic inflammation in a mouse model of sepsis induced by cecal ligation and puncture. J. Surg. Res. 2012, 174(1):136-141.
100. He Y., et al. Tissue damage-associated 'danger signals' influence T cell responses that promote the progression of pre-neoplasia to cancer. Cancer Res. 2013, 73(2):629-639.
101. Heizmann C.W., Fritz G., Schafer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 2002, 7:d1356-d1368.
102. Heizmann C.W., Ackermann G.E., Galichet A. Pathologies involving the S100 proteins and RAGE. Subcell. Biochem. 2007, 45:93-138.
103. Hiratsuka S., et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 2008, 10(11):1349-1355.
104. Hofmann M.A., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97(7):889-901.
105. Holdenrieder S., et al. Clinical relevance of circulating nucleosomes in cancer. Ann. N.Y. Acad. Sci. 2008, 1137:180-189.
106. Hou W., et al. Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death Dis. 2013, 4:e966.
107. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134(5):703-707.
108. Hsu A.L., Murphy C.T., Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003, 300(5622):1142-1145.
109. Hu Z., et al. Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging. Genes Dev. 2014, 28(4):396-408.
110. Huang H., et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011, 54(3):999-1008.
111. Huang J., et al. HMGB1 promotes drug resistance in osteosarcoma. Cancer Res. 2012, 72(1):230-238.
112. Huang H., et al. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J. Immunol. 2013, 191(5):2665-2679.
113. Huang H., et al. Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection. Hepatology 2014, 59(5):1984-1997.
114. Huebener P., et al. High-mobility group box 1 is dispensable for autophagy: mitochondrial quality control, and organ function in vivo. Cell Metab. 2014, 19(3):539-547.
115. Huttunen H.J., et al. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res. 2002, 62(16):4805-4811.
116. Jaskelioff M., et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469(7328):102-106.
117. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293(5532):1074-1080.
118. Jiao Y., Wang H.C., Fan S.J. Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Acta Pharmacol. Sin. 2007, 28(12):1957-1967.
119. Jin K. Modern Biological Theories of Aging. Aging Dis. 2010, 1(2):72-74.
120. Kallberg E., et al. S100A9 interaction with TLR4 promotes tumor growth. PLoS One 2012, 7(3):e34207.
121. Kampinga H.H., et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 2009, 14(1):105-111.
122. Kanfi Y., et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483(7388):218-221.
123. Kang R., et al. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(18):7031-7036.
124. Kang R., et al. HMGB1 in cancer: good, bad, or both?. Clin. Cancer Res. 2013, 19(15):4046-4057.
125. Kang R., et al. Intracellular hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology 2014, 146(4):1097-1107.
126. Kang R., et al. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 2014, 33(5):567-577.
127. Kang R., et al. HMGB1 in health and disease. Mol. Aspects Med. 2014, pii: S0098-2997(14)00037-5. [Epub ahead of print]. 10.1016/j.mam.2014.05.001.
128. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441(7092):431-436.
129. Karlic R., et al. Histone modification levels are predictive for gene expression. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(7):2926-2931.
130. Kasinski A.L., Slack F.J. Epigenetics and genetics, microRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 2011, 11(12):849-864.
131. Kawahara T.L., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136(1):62-74.
132. Kim Y.S., et al. SIRT1 modulates high-mobility group box 1-induced osteoclastogenic cytokines in human periodontal ligament cells. J. Cell Biochem. 2010, 111(5):1310-1320.
133. Kimura T., et al. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res. 2013, 73(1):3-7.
134. Kligman D., Hilt D.C. The S100 protein family. Trends Biochem. Sci. 1988, 13(11):437-443.
135. Korolchuk V.I., Menzies F.M., Rubinsztein D.C. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 2010, 584(7):1393-1398.
136. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128(4):693-705.
137. Krawczyk C.M., et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010, 115(23):4742-4749.
138. Krysko D.V., et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 2012, 12(12):860-875.
139. Krysko O., et al. Many faces of DAMPs in cancer therapy. Cell Death Dis. 2013, 4:e631.
140. Kunej T., et al. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat. Res. 2011, 717(1-2):77-84.
141. Kuniyasu H., et al. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J. Pathol. 2002, 196(2):163-170.
142. Kusume A., et al. Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer. Pathobiology 2009, 76(4):155-162.
143. Law J.A., Jacobsen S.E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 2010, 11(3):204-220.
144. Law B.K. Rapamycin: an anti-cancer immunosuppressant?. Crit. Rev. Oncol. Hematol. 2005, 56(1):47-60.
145. Lecker S.H., Goldberg A.L., Mitch W.E. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 2006, 17(7):1807-1819.
146. Leclerc E., et al. Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 2009, 1793(6):993-1007.
147. Li W.et al. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS One 2007, 2(11):e1153.
148. Liang X.H., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402(6762):672-676.
149. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr. Rev. 2007, 65(12 Pt 2):S140-S146.
150. Linnemann D., Skarsfelt T. Regional changes in expression of NCAM, GFAP, and S100 in aging rat brain. Neurobiol. Aging 1994, 15(5):651-655.
151. Liu L., et al. DAMP-mediated autophagy contributes to drug resistance. Autophagy 2011, 7(1):112-114.
152. Liu L., et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 2011, 25(1):23-31.
153. Liu Z., Falo L.D., You Z. Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8T cell-dependent antitumor immunity. J. Immunol. 2011, 187(1):118-125.
154. Liu L., et al. HMGB1-DNA complex-induced autophagy limits AIM2 inflammasome activation through RAGE. Biochem. Biophys. Res. Commun. 2014, 450(1):851-856.
155. Livesey K.M., et al. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res. 2012, 72(8):1996-2005.
156. Lo J.F., et al. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res. 2011, 71(5):1912-1923.
157. Lombard D.B., et al. DNA repair: genome stability, and aging. Cell 2005, 120(4):497-512.
158. Lopez-Otin C., et al. The hallmarks of aging. Cell 2013, 153(6):1194-1217.
159. Lundblad V., Blackburn E.H. An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell 1993, 73(2):347-360.
160. Lunyak V.V., Rosenfeld M.G. Epigenetic regulation of stem cell fate. Hum. Mol. Genet. 2008, 17(R1):R28-R36.
161. Luo W., Semenza G.L. Emerging roles of PKM2 in cell metabolism and cancer progression. Trends Endocrinol. Metab. 2012, 23(11):560-566.
162. Madeo F., Tavernarakis N., Kroemer G. Can autophagy promote longevity?. Nat Cell Biol. 2012, 12(9):842-846.
163. Maiuri M.C., et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8(9):741-752.
164. Martinez P., Blasco M.A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer 2011, 11(3):161-176.
165. Mathew R., et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007, 21(11):1367-1381.
166. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
167. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296(5566):301-305.
168. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat. Immunol. 2007, 8(1):11-13.
169. Mays-Hoopes L.L. DNA methylation in aging and cancer. J. Gerontol. 1989, 44(6):35-36.
170. Melcher A., et al. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 1998, 4(5):581-587.
171. Meng L., Gabai V.L., Sherman M.Y. Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene 2010, 29(37):5204-5213.
172. Meng L., et al. Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 2011, 30(25):2836-2845.
173. Minina E.A., et al. Autophagy mediates caloric restriction-induced lifespan extension in Arabidopsis. Aging Cell 2013, 12(2):327-329.
174. Mittal D., et al. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J. 2010, 29(13):2242-2252.
175. Montecino-Rodriguez E., Berent-Maoz B., Dorshkind K. Causes: consequences, and reversal of immune system aging. J. Clin. Invest. 2013, 123(3):958-965.
176. Moore B.W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 1965, 19(6):739-744.
177. Morimoto R.I. The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:91-99.
178. Morley J.F., Morimoto R.I. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell 2004, 15(2):657-664.
179. Morrow G., et al. Overexpression of the small mitochondrial Hsp22 extends Drosophila life span and increases resistance to oxidative stress. FASEB J. 2004, 18(3):598-599.
180. Mostoslavsky R., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124(2):315-329.
181. Mouchiroud L., et al. Pyruvate imbalance mediates metabolic reprogramming and mimics lifespan extension by dietary restriction in Caenorhabditis elegans. Aging Cell 2011, 10(1):39-54.
182. Moyzis R.K., et al. A highly conserved repetitive DNA sequence: (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. U.S.A. 1988, 85(18):6622-6626.
183. Muller S., et al. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 2001, 20(16):4337-4340.
184. Multhoff G., et al. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells: but not on normal cells. Int. J. Cancer 1995, 61(2):272-279.
185. Munoz-Najar U., Sedivy J.M. Epigenetic control of aging. Antioxid. Redox Signal. 2011, 14(2):241-259.
186. Murrow L., Debnath J. Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu. Rev. Pathol. 2013, 8:105-137.
187. Nicodeme E., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468(7327):1119-1123.
188. Niedernhofer L.J., et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006, 444(7122):1038-1043.
189. Niedzwiecki A., Fleming J.E. Changes in protein turnover after heat shock are related to accumulation of abnormal proteins in aging Drosophila melanogaster. Mech. Ageing Dev. 1990, 52(2-3):295-304.
190. O'Hagan R.C., et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2002, 2(2):149-155.
191. O'Sullivan R.J., Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat. Rev. Mol. Cell Biol. 2010, 11(3):171-181.
192. O'Sullivan R.J., et al. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat. Struct. Mol. Biol. 2010, 17(10):1218-1225.
193. Perez F.P., et al. Longevity pathways: HSF1 and FoxO pathways, a new therapeutic target to prevent age-related diseases. Curr. Aging Sci. 2012, 5(2):87-95.
194. Polanska E., et al. HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction. Chromosoma 2012, 121(4):419-431.
195. Polo S.E., Jackson S.P. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 2011, 25(5):409-433.
196. Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28(10):1057-1068.
197. Portela L.V., et al. The serum S100B concentration is age dependent. Clin. Chem. 2002, 48(6 Pt 1):950-952.
198. Prasad S., Thakur M.K. In vitro acetylation of the liver HMG non-histone proteins and its modulation by spermine and dexamethasone during aging of rats. Mol. Biol. Rep. 1988, 13(4):221-224.
199. Prasad S., Thakur M.K. Distribution of high mobility group proteins in different tissues of rats during aging. Biochem. Int. 1990, 20(4):687-695.
200. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330(6009):1344-1348.
201. Ramasamy R., et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005, 15(7):16R-28R.
202. Rammes A., et al. Myeloid-related protein (MRP) 8 and MRP14: calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 1997, 272(14):9496-9502.
203. Rando O.J., Chang H.Y. Genome-wide views of chromatin structure. Annu. Rev. Biochem. 2009, 78:245-271.
204. Rao S., et al. A dual role for autophagy in a murine model of lung cancer. Nat. Commun. 2014, 5:3056.
205. Rehman H.U., Masson E.A. Neuroendocrinology of ageing. Age Ageing 2001, 30(4):279-287.
206. Rezvani H.R., et al. Loss of epidermal hypoxia-inducible factor-1alpha accelerates epidermal aging and affects re-epithelialization in human and mouse. J. Cell Sci. 2011, 124(Pt 24):4172-4183.
207. Richter K., Haslbeck M., Buchner J. The heat shock response: life on the verge of death. Mol. Cell 2010, 40(2):253-266.
208. Rickenbacher A., et al. Fasting protects liver from ischemic injury through Sirt1-mediated downregulation of circulating HMGB1 in mice. J. Hepatol. 2014, 61(2):301-308.
209. Rodier F., Campisi J. Four faces of cellular senescence. J. Cell Biol. 2011, 192(4):547-556.
210. Rodier F., Campisi J., Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 2007, 35(22):7475-7484.
211. Roth J., Goebeler M., Sorg C. S100A8 and S100A9 in inflammatory diseases. Lancet 2001, 357(9261):p1041.
212. Rubartelli A., Lotze M.T. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007, 28(10):429-436.
213. Saito K., Dai Y., Ohtsuka K. Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells. Exp. Cell Res. 2005, 310(1):229-236.
214. Sancar A., et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
215. Sasahira T., et al. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. Virchows Arch. 2005, 446(4):411-415.
216. Sasahira T., et al. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma. Virchows Arch. 2007, 450(3):287-295.
217. Satoh A., et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 2013, 18(3):416-430.
218. Sauve A.A., et al. The biochemistry of sirtuins. Annu. Rev. Biochem. 2006, 75:435-465.
219. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418(6894):191-195.
220. Schafer B.W., Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 1996, 21(4):134-140.
221. Schmidt-Hansen B., et al. Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay. J. Biol. Chem. 2004, 279(23):24498-24504.
222. Sebastian C., et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2012, 151(6):1185-1199.
223. Semenza G.L. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:347-353.
224. Senovilla L., et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012, 337(6102):1678-1684.
225. Seo K., et al. Heat shock factor 1 mediates the longevity conferred by inhibition of TOR and insulin/IGF-1 signaling pathways in C. elegans. Aging Cell 2013, 12(6):1073-1081.
226. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4(6):469-478.
227. Sfeir A., de Lange T. Removal of shelterin reveals the telomere end-protection problem. Science 2012, 336(6081):593-597.
228. Shapiro L.A., Marks A., Whitaker-Azmitia P.M. Increased clusterin expression in old but not young adult S100B transgenic mice: evidence of neuropathological aging in a model of Down Syndrome. Brain Res. 2004, 1010(1-2):17-21.
229. Sherman M., Multhoff G. Heat shock proteins in cancer. Ann. N.Y. Acad. Sci. 2007, 1113:192-201.
230. Shi L.Z., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 2011, 208(7):1367-1376.
231. Shin B.K., et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 2003, 278(9):7607-7616.
232. Shinmura K., et al. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 2007, 116(24):2809-2817.
233. Shyh-Chang N., et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013, 339(6116):222-226.
234. Simm A., et al. Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction. Exp. Gerontol. 2004, 39(3):407-413.
235. Slomnicki L.P., Lesniak W. S100A6 (calcyclin) deficiency induces senescence-like changes in cell cycle, morphology and functional characteristics of mouse NIH 3T3 fibroblasts. J. Cell Biochem. 2010, 109(3):576-584.
236. Smith-Vikos T., Slack F.J. MicroRNAs and their roles in aging. J. Cell Sci. 2012, 125(Pt 1):7-17.
237. Sorci G., et al. RAGE in tissue homeostasis: repair and regeneration. Biochim. Biophys. Acta 2013, 1833(1):101-109.
238. Sparvero L.J., et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med. 2009, 7:17.
239. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2002, 2(3):185-194.
240. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403(6765):41-45.
241. Suto R., Srivastava P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995, 269(5230):1585-1588.
242. Suva M.L., Riggi N., Bernstein B.E. Epigenetic reprogramming in cancer. Science 2013, 339(6127):1567-1570.
243. Taguchi A., et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405(6784):354-360.
244. Takahashi Y., et al. Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy. Blood 2013.
245. Tang D., et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J. Leukoc. Biol. 2007, 81(3):741-747.
246. Tang D., et al. Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J. Immunol. 2007, 178(11):7376-7384.
247. Tang D., et al. The anti-inflammatory effects of heat shock protein 72 involve inhibition of high-mobility-group box 1 release and proinflammatory function in macrophages. J. Immunol. 2007, 179(2):1236-1244.
248. Tang D., et al. Quercetin prevents lipopolysaccharide-induced HMGB1 release and proinflammatory function. Am. J. Respir. Cell. Mol. Biol. 2009, 41(6):651-660.
249. Tang D., et al. High-mobility group box 1 and cancer. Biochim. Biophys. Acta 2010, 1799(1-2):131-140.
250. Tang D., et al. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 2010, 190(5):881-892.
251. Tang D., et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29(38):5299-5310.
252. Tang D., et al. High-mobility group box 1: oxidative stress, and disease. Antioxid. Redox Signal. 2011, 14(7):1315-1335.
253. Tang D., et al. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab. 2011, 13(6):701-711.
254. Tang D., et al. High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxid. Redox Signal. 2011, 15(8):2185-2195.
255. Tang D., et al. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol. Rev. 2012, 249(1):158-175.
256. Tang D., et al. HMGB1 phenotypic role revealed with stress. Mol. Med. 2014, 20(1):359-362.
257. Tatar M., Khazaeli A.A., Curtsinger J.W. Chaperoning extended life. Nature 1997, 390(6655):30.
258. Thakur M.K., Prasad S. Analysis of age-associated alteration in the synthesis of HMG nonhistone proteins of the rat liver. Mol. Biol. Rep. 1991, 15(1):19-24.
259. Tian J., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007, 8(5):487-496.
260. Tiu S.C., et al. Differential expression of S100B and S100A6(1) in the human fetal and aged cerebral cortex. Brain Res. Dev. Brain Res. 2000, 119(2):159-168.
261. Tosato M., et al. The aging process and potential interventions to extend life expectancy. Clin. Interv. Aging 2007, 2(3):401-412.
262. Toth C., Martinez J., Zochodne D.W. RAGE: diabetes, and the nervous system. Curr. Mol. Med. 2007, 7(8):766-776.
263. Tower J. Hsps and aging. Trends Endocrinol. Metab. 2009, 20(5):216-222.
264. Tsan M.F., Gao B. Heat shock proteins and immune system. J. Leukoc. Biol. 2009, 85(6):905-910.
265. Tsung A., et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 2007, 204(12):2913-2923.
266. Turchinovich A., et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39(16):7223-7233.
267. van Beijnum J.R., et al. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene 2013, 32(3):363-374.
268. van Heemst D. Insulin, IGF-1 and longevity. Aging Dis. 2010, 1(2):147-157.
269. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324(5930):1029-1033.
270. Vasto S., et al. Inflammation, ageing and cancer. Mech. Ageing Dev. 2009, 130(1-2):40-45.
271. Vera E., et al. Epigenetic regulation of telomeres in human cancer. Oncogene 2008, 27(54):6817-6833.
272. Vijg J., Suh Y. Genome instability and aging. Annu. Rev. Physiol. 2013, 75:645-668.
273. Vogl T., et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4: promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13(9):1042-1049.
274. Waldmann T., Schneider R. Targeting histone modifications-epigenetics in cancer. Curr. Opin. Cell Biol. 2013, 25(2):184-189.
275. Wang W., Lotze M.T. Good things come in small packages: exosomes, immunity and cancer. Cancer Gene Ther. 2014, 21(4):139-141.
276. Wang H., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285(5425):248-251.
277. Wang H.D., Kazemi-Esfarjani P., Benzer S. Multiple-stress analysis for isolation of Drosophila longevity genes. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(34):12610-12615.
278. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12(6):401-410.
279. Wong K.K., et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 2003, 421(6923):643-648.
280. Wu D., et al. Apoptotic release of histones from nucleosomes. J. Biol. Chem. 2002, 277(14):12001-12008.
281. Xu J., et al. Extracellular histones are major mediators of death in sepsis. Nat. Med. 2009, 15(11):1318-1321.
282. Xu J., et al. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J. Immunol. 2011, 187(5):2626-2631.
283. Xu L., Li S., Stohr B.A. The role of telomere biology in cancer. Annu. Rev. Pathol. 2013, 8:49-78.
284. Xu J., et al. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ. 2014, 21(8):1229-1239.
285. Yanai H., et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc. Natl. Acad. Sci. U.S.A. 2013, 110(51):20699-20704.
286. Yang L., et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in Sepsis. Nat. Commun. 2014, 5:4436.
287. Yang M., et al. S100A8 contributes to drug resistance by promoting autophagy in leukemia cells. PLoS One 2014, 9(5):e97242.
288. Yokoyama K., et al. Extended longevity of Caenorhabditis elegans by knocking in extra copies of hsp70F, a homolog of mot-2 (mortalin)/mthsp70/Grp75. FEBS Lett. 2002, 516(1-3):53-57.
289. Youm Y.H., et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013, 18(4):519-532.
290. Yu E.Y., et al. Regulation of telomere structure and functions by subunits of the INO80 chromatin remodeling complex. Mol. Cell. Biol. 2007, 27(16):5639-5649.
291. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9(11):798-809.
292. Zhang Q., et al. DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death. Autophagy 2013, 9(4):451-458.
293. Zhao Z., et al. A dual role for UVRAG in maintaining chromosomal stability independent of autophagy. Dev Cell 2012, 22(5):1001-1016.
294. Zitvogel L., et al. Inflammasomes in carcinogenesis and anticancer immune responses. Nat. Immunol. 2012, 13(4):343-351.